在临床实践中转换为布里瓦拉塞坦单疗法:一项回顾性研究
Simona Lattanzi1, Nicoletta Foschi2, Chiara Martellino3
1Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, 60020, Ancona, Italy. alfierelattanzisimona@gmail.com.
Neurology and therapy
|February 1, 2024
概括
布里瓦拉塞坦 (BRV) 单疗法在焦点的成年人中显示出高的保留率 (88.6%在6个月内) 和发作自由率 (72.7%在6个月内). 这项实践研究表明,BRV在集中性发作管理中是有效和安全的.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 临床实践 临床实践
背景情况:
- 焦点影响了许多成年人,需要有效的单一治疗选择.
- 现实世界的数据对于了解临床试验之外的治疗有效性至关重要.
研究的目的:
- 评估布里瓦拉 (BRV) 作为焦点的成年人转换单疗法的实际有效性和安全性.
- 评估与BRV单一治疗相关的治疗延续率,发作自由率和不良事件.
主要方法:
- 追溯性,观察性,非干预性研究设计.
- 包括成年患者的焦点转换为BRV单疗法.
- 主要结果的评估:在6个月和12个月的BRV保留率;次要结果:发作自由,不良事件.
主要成果:
- 高水平的BRV单疗保留率:88.6%在6个月和83.9%在12个月.
- 显著的发作自由率:72.7%在6个月和58.1%在12个月.
- 不良事件发生率低 (13.6%),睡眠是最常见的;4.5%因AE停止治疗.
结论:
- 在现实世界的临床实践中,布里瓦拉塞坦单一疗法显示出作为焦点的有价值的治疗选择的前景.
- BRV表现出有利的有效性和安全性,特别是对于从 levetiracetam 转换的患者.
更多相关视频
相关概念视频
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
303
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
303
01:15Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
01:28Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
01:01Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:30Electroconvulsive Therapy
41
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
41